Creative Biolabs Recombinant Antibodies
Products
  1. Home
  2. TNF
  3. Anti-TNF alpha Therapeutic Antibody (nerelimomab)

nerelimomab (TAB-768)

Recombinant mouse monoclonal antibody expressed in CHO binding to human TNF alpha. Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.      
Datasheet
Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
Mouse
Derivation
Mouse
Type
IgG1
Species Reactivity
Human
Applications
Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
CAS NO.
162774-06-3
Generic Name
nerelimomab
Related Disease
Unknown
Target
Alternative Names
nerelimomab; 162774-06-3; BAYX-1351; BAY X 1351; TNF; tumor necrosis factor; TNFA, tumor necrosis factor (TNF superfamily, member 2); DIF
Entrez Gene ID
7124
UniProt ID
P01375

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

See other products for "TNF"
Recombinant Mouse Anti-TNF Antibody (CBL940)    ( NEUT-2093CQ )
Anti-Human TNF Therapeutic Antibody (Vh5/Vk12)    ( TAB-116CQ )
Anti-Human TNF Therapeutic Antibody (Humira)    ( TAB-010 )
Anti-Human TNF alpha Therapeutic Antibody (Simponi)    ( TAB-062 )
Anti-Human TNF Therapeutic Antibody Fab Fragment (4H16)    ( TAB-136CQ-F(E) )
Recombinant Mouse Anti-TNF Antibody (CBL516)    ( NEUT-2073CQ )
Anti-Human TNF Therapeutic Antibody scFv Fragment (L4h4)    ( TAB-119CQ-S(P) )
Anti-Human TNF Therapeutic Antibody scFv Fragment (7B4L)    ( TAB-143CQ-S(P) )
>> MORE
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved